Foresight LabsA jacket, two journeys

European Economic Area

EU Reopens Glyphosate Carcinogenicity Review, Triggering Regulatory Reassessment

The EU has initiated a formal re-evaluation of glyphosate’s carcinogenicity, a move that may reshape compliance duties and operational strategies across the chemical and manufacturing value chains.

Published in July 2025. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

2 min readAI-drafted, expert reviewed

Plants

The European Chemicals Agency (ECHA) has been tasked by the European Commission to re-evaluate the carcinogenicity classification of glyphosate following new scientific findings. This development could significantly affect regulatory compliance and product risk assessments for professionals across the chemicals, agriculture, and manufacturing sectors.

New Evidence Spurs Review Of Glyphosate Risks

On 26 June 2025, ECHA formally requested its Committee for Risk Assessment (RAC) to reassess its 2022 opinion on glyphosate’s classification. The review follows a June 2025 study published in Environmental Health by the Ramazzini Institute, which reported potential carcinogenic effects from long-term glyphosate exposure in laboratory animals.

Glyphosate, chemically known as N-(phosphonomethyl)glycine, is a widely used herbicide (EC: 213-997-4; CAS: 1071-83-6) in agricultural, industrial, and domestic applications. The substance is currently classified in the EU as causing serious eye damage and posing chronic aquatic toxicity, but not as carcinogenic.

This reassessment could lead to regulatory reclassification, altering obligations under REACH (Regulation (EC) No 1907/2006).

Implications For Industry And Compliance

The Commission has instructed ECHA to obtain raw data from the Ramazzini Institute’s “Global Glyphosate Study,” which will underpin the new RAC evaluation. Upon receipt, RAC will have 15 months to issue an updated opinion.

Any change in glyphosate’s classification could trigger wide-reaching consequences, including reformulation of products, revised labelling, worker safety protocols, and potential market restrictions. This would affect not only chemical manufacturers but also stakeholders in agriculture, food production, and logistics.

For compliance teams, this development warrants close monitoring. A shift in classification could reframe glyphosate as a substance of very high concern (SVHC), escalating authorisation requirements and regulatory costs.

Official source

echa.europa.eu

Questions about this change

Why is glyphosate’s carcinogenicity being reviewed now?

A 2025 study by the Ramazzini Institute found potential cancer risks from glyphosate exposure. Based on this new evidence, the EU is reassessing its classification to ensure regulatory decisions reflect the latest science.

Is glyphosate currently banned in the EU?

No, glyphosate is not currently banned in the EU. It remains approved for use under strict regulatory controls. However, its authorisation is subject to periodic reviews, and any new health risk findings could impact its legal status.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX